Side effects of Zytiga
Increased alanine aminotransferase and increased aspartate aminotransferase are now listed as common adverse reactions in the summary of product characteristics for Zytiga (abiraterone; Janssen-Cilag). Hepatitis fulminant and acute hepatic failure have been added as rare adverse reactions.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20200824
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.Visit rpharms.com